540694 Stock Overview
Manufactures and sells pharmaceuticals products and formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ANG Lifesciences India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹44.90 |
| 52 Week High | ₹86.06 |
| 52 Week Low | ₹43.50 |
| Beta | 0.46 |
| 11 Month Change | -0.16% |
| 3 Month Change | -7.94% |
| 1 Year Change | -29.55% |
| 33 Year Change | -89.27% |
| 5 Year Change | 167.26% |
| Change since IPO | 16.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540694 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.04% | 2.3% | 2.4% |
| 1Y | -29.5% | 43.8% | 29.5% |
Return vs Industry: 540694 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 540694 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 540694 volatility | |
|---|---|
| 540694 Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540694 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540694's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 433 | Rajesh Gupta | anglifesciences.com |
ANG Lifesciences India Limited manufactures and sells pharmaceuticals products and formulations in India. The company’s products include various therapeutic categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. It offers finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, prefilled syringes, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions.
ANG Lifesciences India Limited Fundamentals Summary
| 540694 fundamental statistics | |
|---|---|
| Market cap | ₹586.32m |
| Earnings (TTM) | -₹147.40m |
| Revenue (TTM) | ₹1.08b |
0.5x
P/S Ratio-4.0x
P/E RatioIs 540694 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540694 income statement (TTM) | |
|---|---|
| Revenue | ₹1.08b |
| Cost of Revenue | ₹697.60m |
| Gross Profit | ₹379.20m |
| Other Expenses | ₹526.60m |
| Earnings | -₹147.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -11.29 |
| Gross Margin | 35.22% |
| Net Profit Margin | -13.69% |
| Debt/Equity Ratio | 115.6% |
How did 540694 perform over the long term?
See historical performance and comparison